Solventum Corporation SOLV
Regular-session close
After hours · Nov 20, 4:06 PM ET
- YTD
- +6.64%
- 1 year
- +6.28%
5D -5.20 (-5.82%)
- Market cap
- 14.36B
- Revenue (ttm)
- 8.16B
- Profit margin
- 1.91%
- EPS (ttm)
- 0.89
- Shares out
- 169.96M
- P/E ratio
- 94.94
- Forward P/E
- 11.20
- YTD return
- +6.64%
- 1-year return
- +6.28%
- 50-day average
- 87.27
- Volume
- 630.00K
- Avg volume
- 1.04M
- Open
- 86.41
- Previous close
- 85.80
- Day's range
- 84.13 – 87.11
- 52-week range
- 62.38 – 94.16
- Beta
- 0.75
- Analysts
- Buy
- Price target
- 98.38 (+16.4%)
- Earnings date
- Feb 25, 2027
Key statistics
- 200-day average
- 79.05
- Enterprise value
- 19.41B
- PEG ratio
- 1.22
- Price / sales
- 1.76
- Price / book
- 2.99
- Revenue growth
- -7.00%
- Free cash flow
- 180.12M
- Total cash
- 451.00M
- Total debt
- 5.29B
- Return on equity
- 3.19%
- Short % of float
- 3.50%
Fundamental scorecard
4 of 25 checks passed on SOLV’s reported financials
4of 25 checks passed
- Value 0 of 5
- Growth 1 of 5
- Profitability 2 of 5
- Financial health 1 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Analyst view
Consensus: buy
- Target (low)
- 75.00
- Target (mean)
- 98.38
- Target (high)
- 115.00
- Strong buy1
- Buy7
- Hold5
- Sell1
- Strong sell1
Next earnings
Feb 25, 2027
Expected Feb 25, 2027. Consensus EPS estimate 1.77.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 25, 2027 | Dec 30, 2026 | 1.77 | — | — | — |
| Nov 5, 2026 | Sep 30, 2026 | 1.34 | 1.45 | +0.11 | +8.21% |
| Aug 5, 2026 | Jun 30, 2026 | 1.90 | 2.55 | +0.65 | +34.21% |
| May 5, 2026 | Mar 31, 2026 | 1.35 | 1.48 | +0.13 | +9.63% |
| Feb 26, 2026 | Dec 31, 2025 | 1.50 | 1.57 | +0.07 | +4.67% |
| Nov 6, 2025 | Sep 30, 2025 | 1.43 | 1.50 | +0.07 | +4.90% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 6, 2026 | Wells Fargo | main | Equal-Weight | Equal-Weight |
| Nov 6, 2026 | Piper Sandler | reit | Overweight | Overweight |
| Sep 14, 2026 | BTIG | reit | Buy | Buy |
| Aug 6, 2026 | UBS | main | Buy | Buy |
| Aug 6, 2026 | Piper Sandler | main | Overweight | Overweight |
| Aug 6, 2026 | Wedbush | main | Outperform | Outperform |
About Solventum Corporation
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- solventum.com
News
Solventum (SOLV) Boasts Earnings & Price Momentum: Should You Buy?
SOLV Energy Highlights Growing Customer Demand for Full-Lifecycle Infrastructure Partnerships at RE+ 2026 Wells Fargo Maintains Equal-Weight on Solventum, Raises Price Target to $95
Piper Sandler Reiterates Overweight on Solventum, Raises Price Target to $110
Solventum Q3 2026 Earnings Call Transcript Quantinuum Inc. (QNT)
Cerebras Systems Inc. (CBRS)
Keel Infrastructure Corp. (KEEL)
Solventum Corp.
QBEN INFRA AB
Your note
Sign in to keep a note on SOLV — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| 3M CO | Beneficial Owner of more than 10% of a Class of Security | Sale | Aug 14, 2025 | 25,569,200 |
| COX CARRIE SMITH | Director | Conversion of Exercise of derivative security | Apr 29, 2026 | 16,400 |
| GOMEZ TAMMY L | Officer | Conversion of Exercise of derivative security | May 12, 2026 | 13,362 |
| HANSON BRYAN CRAIG | Chief Executive Officer | Conversion of Exercise of derivative security | Aug 31, 2026 | 185,515 |
| HARRINGTON PAUL S | Officer | Conversion of Exercise of derivative security | May 12, 2026 | 20,452 |
| KIRBERGER MARCELA A. | Officer | Conversion of Exercise of derivative security | May 12, 2026 | 13,540 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Independent Franchise Partners, LLP | 9.23% | 15,672,189 | 1.32B | Sep 29, 2026 |
| Blackrock Inc. | 5.63% | 9,556,768 | 807.69M | Sep 29, 2026 |
| Vanguard Capital Management LLC | 5.58% | 9,477,019 | 800.95M | Sep 29, 2026 |
| Trian Fund Management, LP | 4.85% | 8,236,753 | 696.13M | Sep 29, 2026 |
| Davis Selected Advisers | 3.78% | 6,414,315 | 542.11M | Sep 29, 2026 |
| Vanguard Portfolio Management LLC | 3.65% | 6,202,062 | 524.17M | Sep 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.75% | 4,674,934 | 395.10M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.25% | 3,816,022 | 322.51M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.99% | 3,375,087 | 285.25M | Jun 29, 2026 |
| John Hancock Funds III-Disciplined Value Mid Cap Fund | 1.41% | 2,385,590 | 201.62M | Sep 29, 2026 |
| Invesco Exchange-Traded Fund Trust-Invesco S&P 500 Equal Weight ETF | 1.28% | 2,172,808 | 183.63M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | 1.26% | 2,138,463 | 180.73M | Jun 29, 2026 |
